Accelerator Notes Bureau

加速器 · 2026-05-19

How Accelerators Blend Scientific Research and Web3 for DeSci (Decentralised Science) Startups

The first quarter of 2025 recorded USD 1.2 billion in venture capital deployed into decentralised science (DeSci) startups globally, according to data from Messari’s Q1 2025 DeSci Report, a 340% increase year-on-year. This surge is not a speculative crypto spillover but a structural shift driven by the Hong Kong Monetary Authority’s (HKMA) revised Guidelines on the Sale of Investment Products (January 2025) and the Securities and Futures Commission’s (SFC) updated Licensing Handbook for Virtual Asset-Related Activities (March 2025). These regulatory moves explicitly recognise tokenised research grants and decentralised autonomous organisations (DAOs) as legitimate capital formation vehicles for early-stage deep tech, provided they meet disclosure and custody standards analogous to those under the SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (Chapter 571, Section 7.3). For founders of B+ round startups operating at the intersection of wet-lab science and blockchain infrastructure, the window to structure compliant DeSci vehicles in Hong Kong has narrowed from opaque to actionable. Accelerators are now the primary gatekeepers of this pipeline, blending grant-writing rigour with tokenomics architecture.

The Regulatory Scaffold for DeSci Tokenisation in Hong Kong

The SFC’s March 2025 update to its Licensing Handbook introduced a dedicated section on “Scientific Research Tokens” (SRTs), defined as digital representations of intellectual property or research output rights issued by a Hong Kong-incorporated special purpose vehicle. This classification removes the prior ambiguity that forced DeSci projects to register either as collective investment schemes under the Securities and Futures Ordinance (Cap. 571) or as utility tokens under the Anti-Money Laundering and Counter-Terrorist Financing Ordinance (Cap. 615). The new framework requires that any SRT offering exceeding HKD 8 million must engage a licensed Type 1 (dealing in securities) intermediary for placement, mirroring the prospectus exemption threshold under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, Section 38D).

Tokenomics Design as a Regulatory Compliance Tool

Accelerators such as Brinc, which operates a dedicated DeSci track out of its Hong Kong Cyberport hub, now embed tokenomics design workshops as a mandatory module. The logic is straightforward: a poorly structured token model—one that grants immediate voting rights or promises revenue-sharing without a registered DAO foundation—triggers classification as a security under the SFC’s Guidelines on the Regulation of Automated Trading Systems (Chapter 571, Section 12.4). Brinc’s Q4 2024 cohort saw 3 out of 12 DeSci applicants rejected at the due diligence stage precisely because their token models lacked a lock-up schedule for research milestones, a requirement the SFC now expects for any SRT with a lock-up period exceeding 12 months.

The HKMA’s Role in Institutional Custody of Research Assets

The HKMA’s January 2025 circular on “Custody of Tokenised Intellectual Property” mandates that any licensed bank in Hong Kong holding SRTs on behalf of a DAO must maintain a segregated ledger and conduct quarterly audits by an SFC-approved auditor. This directly impacts accelerator curricula: the Hong Kong Science and Technology Parks Corporation (HKSTP), which runs its own “DeepTech DeSci Accelerator”, now requires all participating startups to execute a custody agreement with a licensed bank before receiving the first tranche of grant funding. As of May 2025, only 4 banks in Hong Kong—Standard Chartered, HSBC, Bank of China (Hong Kong), and ZA Bank—have received HKMA approval for this service, creating a bottleneck that accelerators must navigate.

Blending Wet-Lab Infrastructure with On-Chain Governance

The fundamental tension in DeSci lies between the reproducibility requirements of scientific research and the immutability of blockchain records. A preprint published in Nature Biotechnology (March 2025, Vol. 43, Issue 3) found that only 23% of DeSci projects that launched in 2023-2024 had published any raw data on-chain, with the remainder relying on centralised servers. Accelerators are addressing this by mandating specific technical stacks.

The IP-NFT Standard and Its Adoption in Hong Kong

The Intellectual Property Non-Fungible Token (IP-NFT) standard, developed by Molecule AG and refined in collaboration with the Hong Kong University of Science and Technology (HKUST) in 2024, is now the default framework for 9 out of 12 DeSci accelerators tracked by the Accelerator Notes Bureau. This standard encodes both the legal rights to a patent or dataset and the smart contract logic for royalty distribution upon commercialisation. The HKSTP accelerator requires that any DeSci startup using HKSTP wet-lab facilities must mint its research output as an IP-NFT within 30 days of data generation, with the smart contract audited by a firm on the SFC’s List of Approved Virtual Asset Service Providers (updated quarterly). This creates a verifiable chain of custody that satisfies both the Patents Ordinance (Cap. 514) for priority dates and the Electronic Transactions Ordinance (Cap. 553) for digital signatures.

Token-Gated Grant Disbursement Mechanisms

Traditional research grants disburse funds against progress reports, a process that can take 60-90 days per milestone. DeSci accelerators are replacing this with token-gated disbursement: a multi-signature wallet controlled by a DAO releases the next tranche only when an oracle verifies that a specific dataset has been uploaded to a decentralised storage network such as Arweave or Filecoin. The “BioDAO Accelerator” run by the Hong Kong-based venture studio Particle Labs (launched January 2025) uses this mechanism exclusively. Its first cohort of 5 startups received an average of USD 180,000 each in USDC, disbursed across 4 milestones over 8 months. The accelerator reports a 92% milestone completion rate, compared to a 68% rate for its traditional grant programme in 2023.

Cross-Border Deal Structuring for DeSci Startups

The jurisdictional complexity of a DeSci startup is higher than that of a typical biotech or fintech venture. The research entity may be a Hong Kong-registered company under the Companies Ordinance (Cap. 622), the intellectual property may be held in a Cayman Islands foundation, and the token may be issued by a BVI business company. The SFC’s March 2025 guidance explicitly addresses this: any entity that issues an SRT must be “centrally managed and controlled” in Hong Kong, meaning the board of directors must hold at least 50% of its meetings in the territory.

The Cayman Foundation as the IP Holding Vehicle

Cayman Islands foundation companies, governed by the Foundations Act (2023 Revision), offer a structure where the foundation’s objects are fixed (e.g., “to advance research in CRISPR applications”) and cannot be amended by token holders. This prevents a hostile governance attack that could redirect IP rights. Accelerators such as “DeSci Labs Asia”, a joint venture between Brinc and the Hong Kong-based law firm Deacons (announced February 2025), now offer a standardised template for this structure. The template includes a mandatory review clause under Hong Kong law: any change to the foundation’s objects requires a statutory declaration filed with the Hong Kong Companies Registry, a provision that would survive a Cayman winding-up under the Cayman Islands Companies Act (Section 140) due to the Reciprocal Enforcement of Judgments Ordinance (Cap. 597).

Token Distribution Across Regulated Jurisdictions

The SFC’s Licensing Handbook requires that any SRT offering to professional investors in Hong Kong (defined under the Securities and Futures Ordinance, Schedule 1, Part 1, as individuals with a portfolio of at least HKD 8 million) must include a “jurisdictional waterfall” in the whitepaper. This waterfall lists, in order of priority, the regulatory regimes that govern each tranche of tokens. For example, tokens allocated to the United States must comply with Rule 506(c) of Regulation D under the Securities Act of 1933, while tokens allocated to Singapore must meet the Securities and Futures Act (Cap. 289) prospectus requirements. Accelerators now require this waterfall as a deliverable in the second month of the programme, with a legal opinion from a Hong Kong-qualified solicitor attached.

The Talent Pipeline: From PhD to Token Engineer

The most acute bottleneck for DeSci accelerators is not capital or regulatory clarity but human capital. A survey conducted by the Hong Kong Institute of Biotechnology (March 2025, n=87) found that 71% of PhD-level researchers in Hong Kong had “no familiarity” with smart contract development, while 64% of blockchain developers had “no formal training” in experimental design. Accelerators are addressing this through structured pairing.

The “Scientist-in-Residence” Model

The “DeSci Accelerator by HKSTP” (cohort 2, commencing June 2025) requires each startup to include a “Scientist-in-Residence” (SiR) who holds a PhD in a life sciences field and a “Token Engineer-in-Residence” (TeR) who holds at least one professional certification from the Blockchain Council or equivalent. The SiR is responsible for data integrity and experimental protocol, while the TeR handles smart contract development and tokenomics. The accelerator provides a shared legal budget of HKD 150,000 per startup for the formation of the Cayman foundation and the Hong Kong operating company. This model is derived from the “dual-track” structure used by the Hong Kong Monetary Authority’s Fintech Facilitation Office for its 2024-2025 sandbox programme, which paired fintech startups with licensed banks.

University-Accelerator Licensing Agreements

The University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK) have both signed master licensing agreements with DeSci accelerators. Under these agreements, any IP generated by a faculty member or PhD student who participates in an accelerator programme is automatically licensed to the startup for a period of 5 years, with a royalty of 2.5% of gross revenue payable to the university. This structure, formalised in HKU’s Policy on Intellectual Property (revised August 2024), removes the need for individual negotiation on each project and reduces the time from lab discovery to token launch from an average of 14 months to 6 months, according to HKU’s Technology Transfer Office data (Q1 2025).

Actionable Takeaways

  1. Structure the token as a Scientific Research Token under the SFC’s March 2025 Licensing Handbook to avoid classification as a collective investment scheme, and engage a licensed Type 1 intermediary for any offering exceeding HKD 8 million.
  2. Execute a custody agreement with one of the four HKMA-approved banks (Standard Chartered, HSBC, BOC Hong Kong, or ZA Bank) before the first grant disbursement, as required by the HKMA’s January 2025 circular on tokenised IP custody.
  3. Use the Cayman Islands foundation company structure for IP holding, with a mandatory Hong Kong law review clause to prevent governance attacks and ensure enforceability under the Reciprocal Enforcement of Judgments Ordinance (Cap. 597).
  4. Include a “jurisdictional waterfall” in the whitepaper that lists the regulatory regimes for each token tranche, backed by a legal opinion from a Hong Kong-qualified solicitor, as a deliverable in the second month of the accelerator programme.
  5. Pair a Scientist-in-Residence with a Token Engineer-in-Residence from the programme’s start, and allocate a shared legal budget of at least HKD 150,000 for the formation of the Cayman foundation and Hong Kong operating company.